Upgrade to SI Premium - Free Trial

AIM ImmunoTech (AIM)

0.21 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/17/26)

Latest Headlines

Form 4 AIM ImmunoTech Inc. For: Sep 15 Filed by: Equels Thomas K September 16, 2026 9:15 AM - SEC Filing Form 4 AIM ImmunoTech Inc. For: Sep 14 Filed by: Equels Thomas K September 15, 2026 4:31 PM - SEC Filing Form 8-K AIM ImmunoTech Inc. For: Sep 08 September 14, 2026 4:35 PM - SEC Filing Form 8-K AIM ImmunoTech Inc. For: Sep 03 September 10, 2026 4:36 PM - SEC Filing Form 8-K AIM ImmunoTech Inc. For: Aug 31 September 4, 2026 4:06 PM - SEC Filing Frontier AI models score worse than a coin flip on grammar in some languages, according to TrainAI August 25, 2026 8:00 AM - PR NewsWire Form 8-K AIM ImmunoTech Inc. For: Aug 11 August 11, 2026 8:40 AM - SEC Filing Form 8-K AIM ImmunoTech Inc. For: Aug 07 August 10, 2026 8:41 AM - SEC Filing Form 10-Q AIM ImmunoTech Inc. For: Jun 30 August 7, 2026 4:36 PM - SEC Filing Form 8-K AIM ImmunoTech Inc. For: Jul 31 August 6, 2026 5:23 PM - SEC Filing Form 8-K AIM ImmunoTech Inc. For: Jul 31 August 5, 2026 8:00 AM - SEC Filing Form 8-K AIM ImmunoTech Inc. For: Jul 15 July 16, 2026 4:06 PM - SEC Filing Form S-8 AIM ImmunoTech Inc. July 9, 2026 4:06 PM - SEC Filing AIM ImmunoTech Announces Release of New CEO Corner Segment Highlighting Growing Momentum Across Pancreatic Cancer Program July 7, 2026 9:03 AM - Globe NewsWire Form DEF 14A AIM ImmunoTech Inc. For: Jun 25 June 25, 2026 8:55 AM - SEC Filing Form 424B3 AIM ImmunoTech Inc. June 24, 2026 4:31 PM - SEC Filing AIM ImmunoTech completes DURIPANC enrollment, eyes 2027 data June 24, 2026 8:30 AM - StreetInsider AIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones June 24, 2026 8:29 AM - Globe NewsWire Form EFFECT AIM ImmunoTech Inc. June 24, 2026 6:03 AM - SEC Filing Form 424B3 AIM ImmunoTech Inc. June 18, 2026 4:06 PM - SEC Filing AIM ImmunoTech (AIM) files for 13.08M share offering by selling stockholders June 18, 2026 8:06 AM - StreetInsider Form S-1 AIM ImmunoTech Inc. June 18, 2026 8:01 AM - SEC Filing Full Article List